iShares MSCI EAFE International Index Fund
BTMKX
NASDAQ- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 100 Bellevue Parkway Wilmington DE United States of America 19809
- IPO Date
- Mar 31, 2011
- CIK
- 0000844779
- Website
- ishares.com
- Similar Companies
- Business
- iShares MSCI EAFE International Index Fund (BTMKX) is an open-end mutual fund that seeks to match the performance of the MSCI EAFE Index before fees and expenses by investing at least 80% of its assets in securities of that index or financial instruments with similar economic characteristics; the underlying index comprises large- and mid-cap equities from developed markets in Europe, Australasia, and the Far East, excluding the U.S. and Canada. The fund offers exposure to approximately 700 holdings, with top positions including ASML Holding NV (around 2%), SAP SE, AstraZeneca PLC, Roche Holding AG, Novartis AG, Nestle SA, and HSBC Holdings PLC; sector allocations emphasize financial services (about 20%), industrials (17%), and healthcare (13%), with 98%+ in non-U.S. stocks across regions like Europe and Japan. Managed by BlackRock with a net expense ratio of 0.05%, minimum initial investment of $5 million, and total net assets exceeding $11 billion, it targets institutional investors in the foreign large blend category. Launched on March 31, 2011, as Class K shares of a series originating in 1997, the fund is domiciled in the United States with principal operations under BlackRock, Inc., headquartered in New York. Recent portfolio manager updates effective April 1, 2025, added Peter Sietsema, Matt Waldron, and Steven White alongside Jennifer Hsui, reflecting BlackRock's ongoing enhancements to its index equity team amid stable fund performance (e.g., 3.73% return in 2024 matching benchmark closely) and routine index reconstitution adjustments; no major acquisitions, partnerships, or structural changes reported for the fund in 2024-2025.